| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | prima-1 | CTRPv2 | pan-cancer | AAC | -0.05 | 0.2 |
| mRNA | TPCA-1 | CTRPv2 | pan-cancer | AAC | 0.052 | 0.2 |
| mRNA | Erlotinib | UHNBreast | pan-cancer | AAC | 0.4 | 0.2 |
| mRNA | Bryostatin 1 | GDSC1000 | pan-cancer | AAC | -0.054 | 0.2 |
| mRNA | BRD-K02492147 | CTRPv2 | pan-cancer | AAC | -0.064 | 0.2 |
| mRNA | SZ4TA2 | CTRPv2 | pan-cancer | AAC | -0.09 | 0.2 |
| mRNA | BEC | CTRPv2 | pan-cancer | AAC | 0.11 | 0.2 |
| mRNA | Gefitinib | CTRPv2 | pan-cancer | AAC | -0.058 | 0.2 |
| mRNA | PF-184 | CTRPv2 | pan-cancer | AAC | 0.053 | 0.2 |
| mRNA | ciclopirox | CTRPv2 | pan-cancer | AAC | 0.051 | 0.2 |